We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-5.09%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$745M
AUM Growth
-$51.2M
Cap. Flow
-$4.97M
Cap. Flow %
-0.67%
Top 10 Hldgs %
3.53%
Holding
1,995
New
631
Increased
376
Reduced
341
Closed
636

Top Buys

Rank Stock Value
1
KOD icon
Kodiak Sciences
KOD
+$3.17M
2
CSTM icon
Constellium
CSTM
+$2.67M
3
KTB icon
Kontoor Brands
KTB
+$2.5M
4
SMTC icon
Semtech
SMTC
+$2.34M
5
CXT icon
Crane NXT
CXT
+$2.34M

Top Sells

Rank Stock Value
1
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$2.96M
2
TUP
Tupperware Brands Corporation
TUP
+$2.45M
3
PRTY
Party City Holdco Inc.
PRTY
+$2.4M
4
NVT icon
nVent Electric
NVT
+$2.32M
5
VYX icon
NCR Voyix
VYX
+$2.1M

Sector Composition

Rank Sector Weight
1 Healthcare 16.38%
2 Industrials 16.37%
3 Technology 14.13%
4 Consumer Discretionary 10.96%
5 Financials 10.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNDL icon
1301
Sundial Growers
SNDL
$320M
$93K 0.01%
+13,342
New +$73.8K
NVVE
1302
DELISTED
Nuvve Holding Corp
NVVE
– –
0
– –
VTGN icon
1303
VistaGen Therapeutics
VTGN
$12.8M
$92K 0.01%
+2,466
New +$108K
AQST icon
1304
Aquestive Therapeutics
AQST
$494M
$91K 0.01%
34,769
-63,033
-64% -$184K
KLXE icon
1305
KLX Energy Services
KLXE
$42.3M
$90K 0.01%
+17,462
New +$106K
PDSB icon
1306
PDS Biotechnology
PDSB
$43.4M
$89K 0.01%
+14,321
New +$89K
ADV icon
1307
Advantage Solutions
ADV
$361M
$88K 0.01%
549
-184
-25% -$31.8K
UAMY icon
1308
United States Antimony
UAMY
$1.02B
$88K 0.01%
+136,760
New +$66.8K
VERU icon
1309
Veru
VERU
$37.4M
$88K 0.01%
1,815
-1,725
-49% -$93.7K
ABTC
1310
American Bitcoin Corp
ABTC
$471M
$84K 0.01%
2
-4
-67% -$159K
ATOS icon
1311
Atossa Therapeutics
ATOS
$23.5M
$83K 0.01%
+4,415
New +$89.7K
VTEX icon
1312
VTEX
VTEX
$713M
$83K 0.01%
+13,484
New +$100K
BRDS
1313
DELISTED
Bird Global, Inc.
BRDS
$83K 0.01%
+1,348
New +$120K
NBEV
1314
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$83K 0.01%
+142,248
New +$102K
SURF
1315
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$81K 0.01%
+27,568
New +$96.6K
SPRY icon
1316
ARS Pharmaceuticals
SPRY
$612M
$80K 0.01%
22,894
+11,303
+98% +$49.2K
CRIS icon
1317
Curis
CRIS
$7.83M
$79K 0.01%
83
+29
+54% +$37K
TXMD icon
1318
TherapeuticsMD
TXMD
$24M
$79K 0.01%
+4,170
New +$65.6K
CRNT icon
1319
Ceragon Networks
CRNT
$201M
$78K 0.01%
36,773
-30,393
-45% -$66.4K
NETI
1320
DELISTED
Eneti Inc.
NETI
$76K 0.01%
+11,975
New +$81.2K
FBRX icon
1321
Forte Biosciences
FBRX
$1.57B
$75K 0.01%
+2,060
New +$77.9K
WRAP icon
1322
Wrap Technologies
WRAP
$104M
$74K 0.01%
+27,400
New +$76.1K
BHIL
1323
DELISTED
Benson Hill, Inc.
BHIL
$74K 0.01%
+653
New +$90.4K
OPGN
1324
DELISTED
OpGen, Inc
OPGN
$73K 0.01%
+489
New +$85.6K
RLX icon
1325
RLX Technology
RLX
$2.46B
$72K 0.01%
+40,241
New +$120K
51 52
53
54 55

Similar funds

NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

GSA Capital Partners's Q1 2022 Portfolio in Review

As of Q1 2022, GSA Capital Partners held 1,995 positions worth $745M, down 6.4% from $796M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

GSA Capital Partners's Q1 2022 filing shows 631 new, 376 increased, 341 reduced and 636 closed positions. Its largest new stake was Kodiak Sciences: 81,285 shares worth $628K. The largest sale was State Street Consumer Staples Select Sector SPDR ETF, an estimated $2.96M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Industrials and Technology.

  • GSA Capital Partners's largest Q1 2022 buy was Kodiak Sciences: 81,285 shares worth $628K.
  • GSA Capital Partners added most to UMB Financial in Q1 2022, an estimated $1.88M increase.
  • GSA Capital Partners's biggest Q1 2022 reduction was Cleveland-Cliffs, cutting an estimated $2.09M.
  • GSA Capital Partners fully exited State Street Consumer Staples Select Sector SPDR ETF in Q1 2022, selling an estimated $2.96M.
  • GSA Capital Partners's ten largest holdings make up 3.5% of its $745M portfolio in Q1 2022.
  • GSA Capital Partners opened 631 new positions and closed 636 in Q1 2022.
  • GSA Capital Partners's portfolio value fell 6.4% quarter-over-quarter to $745M.

Based on GSA Capital Partners's 13F filing for Q1 2022, filed 11 May 2022.